These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28743936)

  • 1. HCV elimination - lessons learned from a small Eurasian country, Georgia.
    Nasrullah M; Sergeenko D; Gamkrelidze A; Averhoff F
    Nat Rev Gastroenterol Hepatol; 2017 Jul; 14(8):447-448. PubMed ID: 28743936
    [No Abstract]   [Full Text] [Related]  

  • 2. Excellence in viral hepatitis elimination - Lessons from Georgia.
    Averhoff F; Lazarus JV; Sergeenko D; Colombo M; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Hellard M; Gnes S; Gabunia T; Nasrullah M
    J Hepatol; 2019 Oct; 71(4):645-647. PubMed ID: 31356831
    [No Abstract]   [Full Text] [Related]  

  • 3. Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study.
    Walker JG; Kuchuloria T; Sergeenko D; Fraser H; Lim AG; Shadaker S; Hagan L; Gamkrelidze A; Kvaratskhelia V; Gvinjilia L; Aladashvili M; Asatiani A; Baliashvili D; Butsashvili M; Chikovani I; Khonelidze I; Kirtadze I; Kuniholm MH; Otiashvili D; Sharvadze L; Stvilia K; Tsertsvadze T; Zakalashvili M; Hickman M; Martin NK; Morgan J; Nasrullah M; Averhoff F; Vickerman P
    Lancet Glob Health; 2020 Feb; 8(2):e244-e253. PubMed ID: 31864917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
    Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
    World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meeting of the International Task Force for Disease Eradication, June 2017.
    Wkly Epidemiol Rec; 2017 Sep; 92(37):537-56. PubMed ID: 28914042
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE project.
    van Dijk M; Kracht PAM; Arends JE; Blokzijl H; Burger DM; van Erpecum KJ; van Hoek B; de Knegt RJ; Posthouwer D; Ramsoekh D; Rijnders BJA; Schinkel J; Willemse SB; van der Valk M; Drenth JPH; Behalf Of The HepNed Study Group O
    Neth J Med; 2019 May; 77(4):131-138. PubMed ID: 31502544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
    Tsertsvadze T; Gamkrelidze A; Nasrullah M; Sharvadze L; Morgan J; Shadaker S; Gvinjilia L; Butsashvili M; Metreveli D; Kerashvili V; Ezugbaia M; Chkhartishvili N; Abutidze A; Kvaratskhelia V; Averhoff F
    BMC Infect Dis; 2020 Jan; 20(1):30. PubMed ID: 31924172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.
    Hagan LM; Kasradze A; Salyer SJ; Gamkrelidze A; Alkhazashvili M; Chanturia G; Chitadze N; Sukhiashvili R; Shakhnazarova M; Russell S; Blanton C; Kuchukhidze G; Baliashvili D; Hariri S; Ko S; Imnadze P; Drobeniuc J; Morgan J; Averhoff F
    BMC Public Health; 2019 May; 19(Suppl 3):480. PubMed ID: 32326913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
    Nasrullah M; Sergeenko D; Gvinjilia L; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Alkhazashvili M; Shadaker S; Ward JW; Morgan J; Averhoff F
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(29):773-776. PubMed ID: 28749925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global elimination of hepatitis C virus by 2030: why not?
    Dore GJ; Martinello M; Alavi M; Grebely J
    Nat Med; 2020 Feb; 26(2):157-160. PubMed ID: 32047317
    [No Abstract]   [Full Text] [Related]  

  • 11. Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.
    Mitruka K; Tsertsvadze T; Butsashvili M; Gamkrelidze A; Sabelashvili P; Adamia E; Chokheli M; Drobeniuc J; Hagan L; Harris AM; Jiqia T; Kasradze A; Ko S; Qerashvili V; Sharvadze L; Tskhomelidze I; Kvaratskhelia V; Morgan J; Ward JW; Averhoff F
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(28):753-7. PubMed ID: 26203628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.
    Rusch U; Robbins S; Razavi H; Vernazza P; Blach S; Bruggmann P; Müllhaupt B; Negro F; Semela D
    Swiss Med Wkly; 2019 Jan; 149():w14694. PubMed ID: 30673118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Risk of HIV and Hepatitis C among Internally Displaced Persons in Georgia.
    Elbaz J
    Ann Glob Health; 2020 Jun; 86(1):66. PubMed ID: 32607311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
    Chikovani I; Ompad DC; Uchaneishvili M; Sulaberidze L; Sikharulidze K; Hagan H; Van Devanter NL
    PLoS One; 2019; 14(4):e0216123. PubMed ID: 31034530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remaining challenges in HCV elimination.
    Capraru C; Feld JJ
    J Hepatol; 2021 Apr; 74(4):964-965. PubMed ID: 33589319
    [No Abstract]   [Full Text] [Related]  

  • 16. Elimination of malaria in country Georgia.
    Kandelaki G; Butsashvili M; Kalandadze I; Iosava M; Avaliani N; Imnadze P
    Acta Trop; 2012 Jul; 123(1):47-8. PubMed ID: 22410541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO Alliance for the Global Elimination of Trachoma by 2020: progress report on elimination of trachoma, 2014–2016.
    Wkly Epidemiol Rec; 2017 Jun; 92(26):359-68. PubMed ID: 28664685
    [No Abstract]   [Full Text] [Related]  

  • 18. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
    Dolmazashvili E; Abutidze A; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1223-1230. PubMed ID: 28857900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.
    Alberti A; Angarano G; Colombo M; Craxì A; Di Marco V; Di Perri G; Gaeta GB; Ippolito G; Mangia A; Pasqualetti P
    Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):190-200. PubMed ID: 30377096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.